Searching for Solutions

Amphetamines and other stimulants are the second most widely used class of (illicit) drugs globally, after cannabis. Specifically, methamphetamine use is rising across the United States (US) and usage is at an all-time high, likely because it is stronger, cheaper and more readily available than ever before.

Physician Fee Schedule Final Rule Released

The 2026 Physician Fee Schedule (PFS) final rule was released late last week by the Centers for Medicare and Medicaid (CMS). The rule makes direct supervision via telehealth permanent for many services. Additionally, it extends audio-only flexibilities for certain non-behavioral health visits through December 31, 2026. It also proposes new add-on codes for behavioral health integration services within Advanced Primary Care Management (APCM) programs. Please note that the rule does retains some COVID-19-era telehealth restrictions, such as the originating site requirement for certain services. We are pleased that these final provisions overall reflect AAPP’s comments to strengthen behavioral health integration in primary care and expand telehealth flexibilities.

This Cannabis Use Disordser toolkit provides tips and guideline summaries in the following areas: Screening Diagnosis Cannabis Intoxication Cannabis Withdrawal Treatment Special Populations and Co-occurring Disorders Harm Reduction Strategies Resources References

The fellowships listed below are related to psychiatric and neurologic pharmacy. The last update to the list was in January 2023. If you would like to make an addition or a change, please email the fellowship details to the AAPP office.

The American Association of Psychiatric Pharmacists (AAPP) is a professional association representing psychiatric pharmacists, residents and aspiring future psychiatric pharmacists (students). AAPP's members are specialized and highly trained in psychiatry, substance use disorders, psychopharmacology, and mitigation of psychosocial factors.